0. Rapid Oxygen Co., LLC. The Portable Oxygen Generation Company,
Presents:
R-90
The Automatic Life Support O2 System.
Proprietary and Confidential

1. Problem: 360,000 patients have cardiac events every day.*
275,000 patients have respiratory events every day.*
5 minutes is the average time for first responders to arrive.*
It only takes 2 minutes without oxygen to start developing brain damage.
* Source: Millwaukee County EMS Activity Report 2013.

2. Current Practices: First responder may be carrying:
Oxygen Cylinders
Oxygen Concentrators
Oxygen Chemical Generators
No public access oxygen system currently in use.
Any oxygen supply currently is supplied by first responders of paramedics.

3. Gas Cylinders:
Limitations: Gas cylinders are a logistical nightmare, stored as pyramid stockpiles around the world. Traditional gas cylinders are heavy, cumbersome, costly to transport & most important, gas cylinders, due to their explosion hazard & terrorist threat, are not permitted in public places.
Cylinders not optimally suited for most places Oxygen is needed including:
AED locations in public places.
Ambulatory O2 Enrichment.
Where EMTs Go.
Where Miner’s Go.
Where Planes Go.
Where Sailors & Soldiers Go.
Surge Capacity/Pandemics.

4. Oxygen Concentrators:
Limitations:
Low Battery life.
Very Noisey
Can be very heavy (Weight)
Requires a doctors prescription for use.
Environmental Limits:
Depends on Quality of ambient air.
O2 delivery is affected by altitude.

5. Chemical Oxygen Generators:
Limitations:
Current chemical oxygen generation systems are relatively heavy and have very limited capacity because of potential runaway chemical reaction.
These systems can be hazardous to handle due to extreme heat. They are bulky because of the number of internal canisters.
They require replenishment canisters which need to be stockpiled. The unit needs to cool down before reuse.
They are fragile and not designed for remote field operation.
Limited self life for canisters

7. 1 2 3 Handle is turned 270º Mixing box using a rock and roll concept
How Does it Work?
Handle is turned 270º
Initiates release of Catalyst triggering reaction to make O2 - Flow will begin
Within 10 seconds 1
Mixing box using a rock and roll concept
Method – before and after turning handle 2
O2 Tubing Connected to Outlet and Mask to Patient
Can be use with either Mask or Nasal Cannula 3

8. R-90 Benefits: Portable Non-Explosive Non-Pressurized
No Maintenance - Single Use Disposable
No foaming/low failure rate
Two year shelf life
Key Differentiators:
No prescription needed: OTC & ‘Good Samaritan’ use extends capability to anywhere a fire extinguisher can be used, including complimenting existing AED installations .
Economical environmentally safe and cost effective.

9. Global Defibrillator AED Market.
2M AED defibrillators sold every year worldwide.
Each location that has an AED would benefit with an easy to use safe oxygen system.
*MDDI, April 2014:10 Transparency Market Research, North America.

10. Global Defibrillator Market.
✓ Assume AED, ASP = $1500
6.2M AED units deployed in 2012
= $620M R-90 market!
 M AED units deployed in 2019
= $947M R-90 market.
= $46.7M/yr. growth.
*MDDI, April 2014:10 Transparency Market Research, North America.

11. AED & R-90 side by side.
Life Support Rescue Station

12. *“Global Defibrillator Market
Bundling Opportunity
*“Global Defibrillator Market
will grow to $14.2B in 2019,
up from $9.3B in 2012”.
CAG = 6.3%..
*MDDI, April 2014:10. Transparency Market Research, North America.

13. Management: Richard Imbruce, PhD, CEO.
30 years experience in the medical device industry & Co-inventor of ALSOS. Founded Pneumedics, Inc., a manufacturer of heart and lung diagnostic instrumentation & advisor to GE/Versamed Healthcare.
Dominic Corsale, VP Marketing.
- Over 30 years experience establishing new medical devices, in particular grew the CO2 and multi-gas sensor market to more than $1B with five different corporations. Instrumental in establishing new practice guidelines and mandates in anesthesia, critical care, procedural sedation and pain management.
Andrew Kersey, VP Manufacturing.
- Over 20 years experience in medical devices. Recent COO of CASD, a medical device manufacturer of patient monitors.
Michael Jaffe, PhD, VP Engineering.
years Advanced Technology Project Manager at Novametrix, Respironics and Phillips Medical.
Kevin Ward, M.D., Medical Director.
- Dr. Ward is a co-inventor of the oxygen generation devices and holds
multiple patents licensed to industrial partner through UM.

14. Contact Richard Imbruce, Ph.D. Rapid Oxygen Co, LLC. (203) 259-0559